Article
Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
Journal of neurology - 1 Sept 1999
Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto A M, Lehtovirta M, Ryynänen M, Soininen H
Abstract excerpt
Apolipoprotein E (APOE) epsilon4 allele is a major risk factor for the development of Alzheimer's disease (AD). It has been suggested that the quantitative expression of APOE alleles results from mutations in the promoter region of this gene. We studied the -491A/T promoter polymorphism and whether it is dependent on the APOE epsilon4 allele in clinic-based AD (n = 106) and community-based control (n = 123)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
